UPB-101 + Placebo
Phase 1Completed 0 watching 0 views this week๐ค Quiet
25
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Asthma
Conditions
Asthma
Trial Timeline
Jul 8, 2022 โ Oct 5, 2023
NCT ID
NCT05448651About UPB-101 + Placebo
UPB-101 + Placebo is a phase 1 stage product being developed by Upstream Bio for Asthma. The current trial status is completed. This product is registered under clinical trial identifier NCT05448651. Target conditions include Asthma.
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05448651 | Phase 1 | Completed |
Competing Products
20 competing products in Asthma